Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.

Abstract:

:Cancer cells can use a variety of metabolic substrates to fulfill the bioenergetic and biosynthetic needs of their oncogenic program. Besides bioenergetics, cancer cell metabolism also directly influences genetic, epigenetic and signaling events associated with tumor progression. Many cancer cells are addicted to glutamine, and this addiction is observed in oxidative as well as in glycolytic cells. Although both oxidative and bioreductive glutamine metabolism can contribute to cancer progression and glutamine can further serve to generate peptides (including glutathione) and proteins, we report that glutamine promotes the proliferation of cancer cells independently of its use as a metabolic fuel or as a precursor of glutathione. Extracellular glutamine activates transcription factor signal transducer and activator of transcription 3 (STAT3), which is necessary and sufficient to mediate the proliferative effects of glutamine on glycolytic and oxidative cancer cells. Glutamine also activates transcription factors hypoxia-inducible factor-1, mammalian target of rapamycin and c-Myc, but these factors do not mediate the effects of glutamine on cancer cell proliferation. Our findings shed a new light on the anticancer effects of l-asparaginase that possesses glutaminase activity and converts glutamine into glutamate extracellularly. Conversely, cancer resistance to treatments that block glutamine metabolism could arise from glutamine-independent STAT3 reactivation.

journal_name

Oncogene

journal_title

Oncogene

authors

Cacace A,Sboarina M,Vazeille T,Sonveaux P

doi

10.1038/onc.2016.364

subject

Has Abstract

pub_date

2017-04-01 00:00:00

pages

2074-2084

issue

15

eissn

0950-9232

issn

1476-5594

journal_volume

36

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Transcriptional and post-transcriptional induction of the TGFalpha gene in transformed rat liver epithelial cells.

    abstract::Although TGFalpha mRNA and protein are frequently elevated in neoplastic cells, neither the level at which deregulation occurs nor the mechanism(s) responsible have been well characterized. As a first step, we examined the induction of TGFalpha mRNA in two series of clonally-derived rat liver epithelial cell lines tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Berkowitz EA,Hissong MA,Lee DC

    更新日期:1996-05-02 00:00:00

  • Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in glioma.

    abstract::Matrix metalloproteinase-2 (MMP-2) has pivotal role in the degradation of extracellular matrix, and thereby enhances the invasive, proliferative and metastatic potential in cancer. Knockdown of MMP-2 using MMP-2 small interfering RNA (pM) in human glioma xenograft cell lines 4910 and 5310 decreased cell proliferation ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.52

    authors: Kesanakurti D,Chetty C,Dinh DH,Gujrati M,Rao JS

    更新日期:2013-01-17 00:00:00

  • All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.

    abstract::Wilms tumor is one of the most frequent neoplasias in children. Our previous microarray screening in a large series of Wilms tumors revealed several candidate genes that are deregulated in advanced tumors and are part of the retinoic acid signaling pathway. To investigate whether retinoic acid could be employed as a n...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208725

    authors: Zirn B,Samans B,Spangenberg C,Graf N,Eilers M,Gessler M

    更新日期:2005-08-04 00:00:00

  • Mouse Neogenin, a DCC-like molecule, has four splice variants and is expressed widely in the adult mouse and during embryogenesis.

    abstract::Neogenin is a member of the N-CAM family of cell adhesion molecules and is closely related to the DCC tumor suppressor gene product. Recently, it has been demonstrated that the DCC/Neogenin subfamily plays a key role in axonal guidance within the embryonic nervous system, however little is known about the function of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201225

    authors: Keeling SL,Gad JM,Cooper HM

    更新日期:1997-08-07 00:00:00

  • TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior.

    abstract::Treatment options for adenoid cystic carcinoma (ACC) of the salivary gland, a slowly growing tumor with propensity for neuroinvasion and late recurrence, are limited to surgery and radiotherapy. Based on expression analysis performed on clinical specimens of salivary cancers, we identified in ACC expression of the neu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.377

    authors: Ivanov SV,Panaccione A,Brown B,Guo Y,Moskaluk CA,Wick MJ,Brown JL,Ivanova AV,Issaeva N,El-Naggar AK,Yarbrough WG

    更新日期:2013-08-08 00:00:00

  • Identification of AFAP1L1 as a prognostic marker for spindle cell sarcomas.

    abstract::Spindle cell sarcomas consist of tumors with different biological features, of which distant metastasis is the most ominous sign for a poor prognosis. However, metastasis is difficult to predict on the basis of current histopathological analyses. We have identified actin filament-associated protein 1-like 1 (AFAP1L1) ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.108

    authors: Furu M,Kajita Y,Nagayama S,Ishibe T,Shima Y,Nishijo K,Uejima D,Takahashi R,Aoyama T,Nakayama T,Nakamura T,Nakashima Y,Ikegawa M,Imoto S,Katagiri T,Nakamura Y,Toguchida J

    更新日期:2011-09-22 00:00:00

  • Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene.

    abstract::We have isolated a candidate tumor suppressor gene from a 600-kb region on chromosome 8p21.3-p22 that is commonly deleted in sporadic hepatocellular carcinomas (HCC), colorectal cancers (CRC), and non-small cell lung cancers (NSCLC). As this gene encodes a protein of 375 amino acids that bears significant sequence sim...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Fujiwara Y,Ohata H,Kuroki T,Koyama K,Tsuchiya E,Monden M,Nakamura Y

    更新日期:1995-03-02 00:00:00

  • Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer.

    abstract::Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208325

    authors: May D,Itin A,Gal O,Kalinski H,Feinstein E,Keshet E

    更新日期:2005-02-03 00:00:00

  • Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.

    abstract::Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with high-grade cervical dysplasia and with invasive squamous carcinoma of the cervix. Vascular endothelial cell growth factor (VEGF) is known to be one of the most important inducers of angiogenesis and is upregulated in carcinoma of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203817

    authors: López-Ocejo O,Viloria-Petit A,Bequet-Romero M,Mukhopadhyay D,Rak J,Kerbel RS

    更新日期:2000-09-21 00:00:00

  • Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.

    abstract::Transforming growth factor beta1 (TGF-beta1) belongs to a family of polypeptide factors, whose cytostatic and apoptotic functions help restrain the growth of mammalian cells. Although solid data established the role of TGF-beta's as suppressor factors in tumorigenic processes, in the context of an advanced stage of di...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208664

    authors: Murillo MM,del Castillo G,Sánchez A,Fernández M,Fabregat I

    更新日期:2005-06-30 00:00:00

  • Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence.

    abstract::A hallmark of human cancer is heterogeneity, reflecting the complex series of changes resulting in the activation of oncogenes coupled with inactivation of tumor suppressor genes. Breast cancer is no exception and indeed, many studies have revealed considerable complexity and heterogeneity in the population of primary...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.433

    authors: Leung JY,Andrechek ER,Cardiff RD,Nevins JR

    更新日期:2012-05-17 00:00:00

  • Functional interactions within adenovirus E1A protein complexes.

    abstract::The transforming potential of adenovirus E1A oncogene products derives largely from the formation of complexes with cellular proteins, including the p105Rb tumor suppressor and a related p107 species, p130 and p300 proteins, and cyclin A (p60cycA). Extensive quantitative analyses using E1A deletion mutants identified ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Barbeau D,Charbonneau R,Whalen SG,Bayley ST,Branton PE

    更新日期:1994-02-01 00:00:00

  • Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas.

    abstract::Telomerase activation is crucial in human carcinogenesis. The limiting component of telomerase, the catalytic subunit (hTERT), is undetectable in normal somatic cells but present in most tumor cells, including the earliest stages of colon carcinoma. The mechanisms involved in the differential expression in normal and ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204346

    authors: Szutorisz H,Palmqvist R,Roos G,Stenling R,Schorderet DF,Reddel R,Lingner J,Nabholz M

    更新日期:2001-05-03 00:00:00

  • Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.

    abstract::p66(Shc), an isoform of Shc adaptor proteins, is shown to mediate various signals, including cellular stress. However, little is known about its involvement in carcinogenesis. We previously showed that p66(Shc) protein level is upregulated by steroid hormones in human carcinoma cells and is higher in prostate cancer (...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208852

    authors: Veeramani S,Igawa T,Yuan TC,Lin FF,Lee MS,Lin JS,Johansson SL,Lin MF

    更新日期:2005-11-03 00:00:00

  • HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.

    abstract::Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204879

    authors: Shamay M,Agami R,Shaul Y

    更新日期:2001-10-18 00:00:00

  • Stable overexpression of MEN1 suppresses tumorigenicity of RAS.

    abstract::Although there is indirect genetic evidence that MEN1, the gene for multiple endocrine neoplasia type 1, is a tumor suppressor gene, little is known about the MEN1-encoded protein, menin. Menin was stably overexpressed in a well-characterized murine tumor cell line, (valine-12)-RAS-transformed NIH3T3 cells. Menin over...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203005

    authors: Kim YS,Burns AL,Goldsmith PK,Heppner C,Park SY,Chandrasekharappa SC,Collins FS,Spiegel AM,Marx SJ

    更新日期:1999-10-21 00:00:00

  • 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.

    abstract::Despite extensive characterization of the role of the EWS-ETS fusions, little is known about secondary genetic alterations and their clinical contribution to Ewing sarcoma (ES). It has been demonstrated that the molecular structure of EWS-ETS lacks prognostic value. Moreover, CDKN2A deletion and TP53 mutation, despite...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.317

    authors: Mackintosh C,Ordóñez JL,García-Domínguez DJ,Sevillano V,Llombart-Bosch A,Szuhai K,Scotlandi K,Alberghini M,Sciot R,Sinnaeve F,Hogendoorn PC,Picci P,Knuutila S,Dirksen U,Debiec-Rychter M,Schaefer KL,de Álava E

    更新日期:2012-03-08 00:00:00

  • TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.

    abstract::TEA domain (TEAD) transcription factors are key components of the Hippo-YAP1 signaling pathway, but their functional role and regulatory mechanisms remain unclear. This study aims to comprehensively explore the expression pattern and functional role of TEAD family in gastric carcinogenesis and investigate its regulati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.257

    authors: Zhou Y,Huang T,Zhang J,Wong CC,Zhang B,Dong Y,Wu F,Tong JHM,Wu WKK,Cheng ASL,Yu J,Kang W,To KF

    更新日期:2017-11-23 00:00:00

  • Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.

    abstract::Fatty acid binding protein 4 (FABP4) is a fatty acid chaperone, which is induced during adipocyte differentiation. Previously we have shown that FABP4 in endothelial cells is induced by the NOTCH1 signalling pathway, the latter of which is involved in mechanisms of resistance to antiangiogenic tumour therapy. Here, we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.256

    authors: Harjes U,Bridges E,Gharpure KM,Roxanis I,Sheldon H,Miranda F,Mangala LS,Pradeep S,Lopez-Berestein G,Ahmed A,Fielding B,Sood AK,Harris AL

    更新日期:2017-02-16 00:00:00

  • Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.

    abstract::Amplification of the N-myc gene is a significant adverse prognostic factor in neuroblastoma, a common childhood tumor. In non-transformed cells, myc expression is controlled through an autoregulatory circuit, through which elevated Myc protein levels lead to down-regulation of myc transcription. The precise mechanism ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201363

    authors: Sivak LE,Tai KF,Smith RS,Dillon PA,Brodeur GM,Carroll WL

    更新日期:1997-10-16 00:00:00

  • Cloning and characterization of a novel gene encoding a putative transmembrane protein with altered expression in some human transformed and tumor-derived cell lines.

    abstract::Identification and characterization of genes expressed in normal cells and decreased in their malignant counterparts is an important method for detecting candidate tumor suppressors. Using differential display of mRNAs from nontumorigenic infinite life span human fibroblast cell strain MSU-1.1 and an isogenic fibrosar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202290

    authors: Qing J,Wei D,Maher VM,McCormick JJ

    更新日期:1999-01-14 00:00:00

  • BAG-1 accelerates cell motility of human gastric cancer cells.

    abstract::BAG-1 is a Hsp70/Hsc70-binding protein that interacts with Bcl-2, Raf-1, steroid hormone receptors, Siah-1, and hepatocyte growth factor (HGF) receptors, implying multiple functions for the BAG-1 protein. Here, we provide evidence that gene transfer-mediated overexpression of BAG-1 markedly enhances the motility of hu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202661

    authors: Naishiro Y,Adachi M,Okuda H,Yawata A,Mitaka T,Takayama S,Reed JC,Hinoda Y,Imai K

    更新日期:1999-05-27 00:00:00

  • SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.

    abstract::Epigenetic regulations play crucial roles in leukemogenesis and leukemia progression. SUV39H1 is the dominant H3K9 methyltransferase in the hematopoietic system, and its expression declines with aging. However, the role of SUV39H1 via its-mediated repressive modification H3K9me3 in leukemogenesis/leukemia progression ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01495-6

    authors: Chu Y,Chen Y,Guo H,Li M,Wang B,Shi D,Cheng X,Guan J,Wang X,Xue C,Cheng T,Shi J,Yuan W

    更新日期:2020-12-01 00:00:00

  • Promoter specificity and stability control of the p53-related protein p73.

    abstract::The p53 family of proteins play instrumental roles in mediating the cellular response to stress. The p53-related gene product, p73, occurs as two distinct protein isoforms, referred to as alpha and beta, which differ in the length of the C-terminal region and arise through alternative splicing of the p73 RNA. Here, we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202793

    authors: Lee CW,La Thangue NB

    更新日期:1999-07-22 00:00:00

  • Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.

    abstract::The osteogenic transcription factor, Runx2, is abnormally expressed in prostate cancer (PCa) and associated with metastatic disease. During bone development, Runx2 is activated by signals known to be hyperactive in PCa including the RAS/MAP kinase pathway, which phosphorylates Runx2 on multiple serine residues includi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.91

    authors: Ge C,Zhao G,Li Y,Li H,Zhao X,Pannone G,Bufo P,Santoro A,Sanguedolce F,Tortorella S,Mattoni M,Papagerakis S,Keller ET,Franceschi RT

    更新日期:2016-01-21 00:00:00

  • The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.

    abstract::EndoA is a type II keratin and with EndoB (type I keratin), constitutes intermediate filaments in various simple epithelial tissues. EndoA is developmentally regulated and has an enhancer that is located at the 3'- end of the gene. This enhancer contains two single and five dual Ets binding sites. Thus far, no other p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Seth A,Robinson L,Panayiotakis A,Thompson DM,Hodge DR,Zhang XK,Watson DK,Ozato K,Papas TS

    更新日期:1994-02-01 00:00:00

  • Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.

    abstract::Gastrin and its precursors promote proliferation in different gastrointestinal cells. Since mature, amidated gastrin (G-17) can induce cyclin D1, we determined whether G-17-mediated induction of cyclin D1 transcription involved Wnt signaling and CRE-binding protein (CREB) pathways. Our studies indicate that G-17 induc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207454

    authors: Pradeep A,Sharma C,Sathyanarayana P,Albanese C,Fleming JV,Wang TC,Wolfe MM,Baker KM,Pestell RG,Rana B

    更新日期:2004-04-29 00:00:00

  • FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.

    abstract::Prostate cancer (PCa) growth is dependent on androgens and on the androgen receptor (AR), which acts by modulating gene transcription. Tetratricopeptide repeat (TPR) proteins (FKBP52, FKBP51 and Cyp40) interact with AR in PCa cells, suggesting roles in AR-mediated gene transcription and cell growth. We report here tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.458

    authors: Periyasamy S,Hinds T Jr,Shemshedini L,Shou W,Sanchez ER

    更新日期:2010-03-18 00:00:00

  • Drosophila asymmetric division, polarity and cancer.

    abstract::A limited number of adult stem cells (SCs) maintain the homoestasis of different tissues through the lifetime of the individual by generating differentiating daughters and renewing themselves. Errors in the SC division rate or in the fine balance between self-renewal and differentiation might result in tissue overgrow...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.349

    authors: Januschke J,Gonzalez C

    更新日期:2008-11-24 00:00:00

  • Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.

    abstract::Imbalances in chromosome 11q occur in approximately 30% of primary neuroblastoma and are associated with poor outcome. It has been suggested that 11q loss constitutes a distinct clinico-genetic neuroblastoma subgroup by affecting expression levels of corresponding genes. This study analysed the relationship of 11q los...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.390

    authors: Fischer M,Bauer T,Oberthür A,Hero B,Theissen J,Ehrich M,Spitz R,Eils R,Westermann F,Brors B,König R,Berthold F

    更新日期:2010-02-11 00:00:00